FIELD: medicine, pharmaceutics.
SUBSTANCE: pharmaceutical composition for the reduction of a primary radiation response and an early transient incapacity containing ondansetron and gastrozepin in mass ratio 1-12:2-15; the composition is used as an injectable dosage form.
EFFECT: what is developed is the new composition.
3 cl, 3 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
MEDICINAL AGENT | 2007 |
|
RU2363463C1 |
PHARMACEUTICAL COMPOSITION COMPRISING ONDANSETRON, METHACINE AND BENZAMIDE | 2003 |
|
RU2234315C1 |
PHARMACEUTICAL COMPOSITION CONTAINING ONDANSETRON AND METHACINE | 2001 |
|
RU2185825C1 |
PHARMACEUTICAL COMPOSITION CONTAINING ONDANSETRON AND BENZAMIDE | 2003 |
|
RU2228752C1 |
ANTIEMETIC AGENT BENZAMIDE | 2002 |
|
RU2205009C1 |
COMBINED COMPOSITION OF SUBSTANCES WITH COMPLEX PHARMACOLOGICAL ACTIVITY | 2014 |
|
RU2622991C2 |
MEDICINAL AGENT | 2002 |
|
RU2229882C2 |
METHOD OF PREVENTING CEREBRAL FORM OF RADIATION SICKNESS | 2013 |
|
RU2537170C1 |
RADIOPROTECTOR | 2010 |
|
RU2428192C1 |
METHOD FOR PREVENTION OF NEUROLOGICAL STATUS AND MUSCULAR TONUS VIOLATIONS IN ACUTE RADIATION DISEASE IN EXPERIMENT | 2016 |
|
RU2638270C2 |
Authors
Dates
2014-03-20—Published
2012-06-28—Filed